General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Lexicon Pharmaceuticals(MODEST) RESEARCH/RESEARCH GRANTS: Bristol Myers Squibb(SIGNIFICANT), Lexicon Pharmaceuticals(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Zoll(MODEST)

View Full Disclosure